Close

Pacific Bio (PACB) Enters HLA co-Marketing Agreement with GenDx

June 19, 2014 7:44 AM EDT Send to a Friend
Pacific Biosciences of California, Inc., (Nasdaq: PACB) and GenDx, a pioneer in the area of sequence-based typing and next-generation sequencing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login